117 related articles for article (PubMed ID: 8527458)
1. Differential effects of ethyl 5-amino-2-methyl-1,2-dihydro-3-phenylpyrido[3,4-b]pyrazin-7-yl carbamate analogs modified at position C2 on tubulin polymerization, binding, and conformational changes.
Barbier P; Peyrot V; Sarrazin M; Rener GA; Briand C
Biochemistry; 1995 Dec; 34(51):16821-9. PubMed ID: 8527458
[TBL] [Abstract][Full Text] [Related]
2. The active GTP- and ground GDP-liganded states of tubulin are distinguished by the binding of chiral isomers of ethyl 5-amino-2-methyl-1,2-dihydro-3-phenylpyrido[3,4-b]pyrazin-7-yl carbamate.
Barbier P; Peyrot V; Leynadier D; Andreu JM
Biochemistry; 1998 Jan; 37(2):758-68. PubMed ID: 9425100
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of association and dissociation of two enantiomers, NSC 613863 (R)-(+) and NSC 613862 (S)-(-) (CI 980), to tubulin.
Barbier P; Peyrot V; Dumortier C; D'Hoore A; Rener GA; Engelborghs Y
Biochemistry; 1996 Feb; 35(6):2008-15. PubMed ID: 8639685
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of microtubules and cell cycle arrest by a new 1-deaza-7,8-dihydropteridine antitumor drug, CI 980, and by its chiral isomer, NSC 613863.
de Ines C; Leynadier D; Barasoain I; Peyrot V; Garcia P; Briand C; Rener GA; Temple C
Cancer Res; 1994 Jan; 54(1):75-84. PubMed ID: 8261466
[TBL] [Abstract][Full Text] [Related]
5. Linkages in tubulin-colchicine functions: the role of the ring C (C') oxygens and ring B in the controls.
Pérez-Ramírez B; Gorbunoff MJ; Timasheff SN
Biochemistry; 1998 Feb; 37(6):1646-61. PubMed ID: 9484236
[TBL] [Abstract][Full Text] [Related]
6. Tubulin binding of two 1-deaza-7,8-dihydropteridines with different biological properties: enantiomers NSC 613862 (S)-(-) and NSC 613863 (R)-(+).
Leynadier D; Peyrot V; Sarrazin M; Briand C; Andreu JM; Rener GA; Temple C
Biochemistry; 1993 Oct; 32(40):10675-82. PubMed ID: 8399213
[TBL] [Abstract][Full Text] [Related]
7. Perturbation of microtubule polymerization by quercetin through tubulin binding: a novel mechanism of its antiproliferative activity.
Gupta K; Panda D
Biochemistry; 2002 Oct; 41(43):13029-38. PubMed ID: 12390030
[TBL] [Abstract][Full Text] [Related]
8. Antimitotic agents: ring analogues and derivatives of ethyl [(S)-5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7- yl]carbamate.
Temple C; Rener GA
J Med Chem; 1992 Dec; 35(26):4809-12. PubMed ID: 1479582
[TBL] [Abstract][Full Text] [Related]
9. Tubulin binding properties of two chiral isomers with 1-deaza-7,8-dihydropteridine structure.
Leynadier D; Peyrot V; Sarrazin M; Andreu JM; Temple C; Rener G; Briand C
Adv Exp Med Biol; 1993; 338():465-8. PubMed ID: 8304159
[No Abstract] [Full Text] [Related]
10. Antimitotic agents. Chiral isomers of ethyl [5-amino-1,2-dihydro-3-(4-hydroxyphenyl)-2-methylpyrido[3,4-b]pyrazin-7 -yl]carbamate.
Temple C; Rener GA
J Med Chem; 1992 Mar; 35(6):988-93. PubMed ID: 1552512
[TBL] [Abstract][Full Text] [Related]
11. Molecular interaction of tubulin with 1-deaza-7,8-dihydropteridines: a comparative study of enantiomers NSC 613862 (S) and NSC 613863 (R) by Raman and Fourier transform infrared spectroscopy.
Allam N; Millot JM; Manfait M; Leynadier D; Peyrot V; Briand C; Temple C
Int J Biol Macromol; 1995 Feb; 17(1):55-60. PubMed ID: 7772564
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of colchicine binding to tubulin. Tolerance of substituents in ring C' of biphenyl analogues.
Andreu JM; Gorbunoff MJ; Medrano FJ; Rossi M; Timasheff SN
Biochemistry; 1991 Apr; 30(15):3777-86. PubMed ID: 2015233
[TBL] [Abstract][Full Text] [Related]
13. The colchicine-induced GTPase activity of tubulin: state of the product. Activation by microtubule-promoting cosolvents.
Perez-Ramirez B; Shearwin KE; Timasheff SN
Biochemistry; 1994 May; 33(20):6253-61. PubMed ID: 8193140
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of active isomers, segments, and analogs of dolastatin 10 on ligand interactions with tubulin. Correlation with cytotoxicity.
Bai R; Roach MC; Jayaram SK; Barkoczy J; Pettit GR; Ludueña RF; Hamel E
Biochem Pharmacol; 1993 Apr; 45(7):1503-15. PubMed ID: 8471072
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the interaction of TZT-1027, a potent antitumor agent, with tubulin.
Natsume T; Watanabe J; Tamaoki S; Fujio N; Miyasaka K; Kobayashi M
Jpn J Cancer Res; 2000 Jul; 91(7):737-47. PubMed ID: 10920282
[TBL] [Abstract][Full Text] [Related]
16. Roles of colchicine rings B and C in the binding process to tubulin.
Medrano FJ; Andreu JM; Gorbunoff MJ; Timasheff SN
Biochemistry; 1989 Jun; 28(13):5589-99. PubMed ID: 2775723
[TBL] [Abstract][Full Text] [Related]
17. Interaction of tubulin with bifunctional colchicine analogues: an equilibrium study.
Andreu JM; Gorbunoff MJ; Lee JC; Timasheff SN
Biochemistry; 1984 Apr; 23(8):1742-52. PubMed ID: 6722122
[TBL] [Abstract][Full Text] [Related]
18. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of binding of the new antimitotic drug MDL 27048 to the colchicine site of tubulin: equilibrium studies.
Peyrot V; Leynadier D; Sarrazin M; Briand C; Menendez M; Laynez J; Andreu JM
Biochemistry; 1992 Nov; 31(45):11125-32. PubMed ID: 1445852
[TBL] [Abstract][Full Text] [Related]
20. Microtubule-disrupting effects of gallium chloride in vitro.
Perchellet EM; Ladesich JB; Collery P; Perchellet JP
Anticancer Drugs; 1999 Jun; 10(5):477-88. PubMed ID: 10477168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
